The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| LINEAGE INC | COM | 53566V106 | 26,112,000 | 600,000 | SH | DFND | 1 | 600,000 | 0 | 0 | |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | 1,557,634 | 2,124,143 | SH | DFND | 1 | 2,124,143 | 0 | 0 | |
| REVOLUTION MEDICINES INC | COM | 76155X100 | 80,798,198 | 2,196,200 | SH | DFND | 1 | 2,196,200 | 0 | 0 | |
| REVOLUTION MEDICINES INC | *W EXP 12/17/202 | 76155X118 | 118,215 | 450,000 | SH | DFND | 1 | 450,000 | 0 | 0 | |
| SAILPOINT INC | COM | 78781J109 | 68,580,000 | 3,000,000 | SH | DFND | 1 | 3,000,000 | 0 | 0 | |
| SAMSARA INC | COM CL A | 79589L106 | 905,035 | 22,751 | SH | DFND | 1 | 22,751 | 0 | 0 | |